State Street Corp Tarsus Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 899,379 shares of TARS stock, worth $47.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

899,379

Previous 925,639 2.84%

Holding current value

$47.9 Million

Previous $25.2 Million 17.58%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.54 - $34.6 $565,640 - $908,596	-26,260 Reduced 2.84%	899,379 $29.6 Million
Q2 2024 Aug 14, 2024	BUY	$25.17 - $38.73 $5.25 Million - $8.08 Million	208,549 Added 29.08%	925,639 $25.2 Million
Q1 2024 May 15, 2024	BUY	$19.61 - $39.22 $828,698 - $1.66 Million	42,259 Added 6.26%	717,090 $26.1 Million
Q4 2023 Feb 14, 2024	BUY	$12.98 - $20.73 $1.69 Million - $2.69 Million	129,899 Added 23.84%	674,831 $13.7 Million
Q3 2023 Nov 14, 2023	BUY	$14.75 - $24.62 $1.83 Million - $3.06 Million	124,216 Added 29.52%	544,932 $9.68 Million
Q2 2023 Aug 14, 2023	BUY	$11.57 - $19.63 $652,790 - $1.11 Million	56,421 Added 15.49%	420,716 $7.6 Million
Q1 2023 May 15, 2023	BUY	$11.92 - $16.27 $210,209 - $286,921	17,635 Added 5.09%	364,295 $4.58 Million
Q4 2022 Feb 14, 2023	BUY	$14.12 - $18.72 $756,111 - $1 Million	53,549 Added 18.27%	346,660 $5.08 Million
Q3 2022 Nov 15, 2022	BUY	$14.08 - $18.5 $796,857 - $1.05 Million	56,595 Added 23.93%	293,111 $5.02 Million
Q2 2022 Aug 15, 2022	BUY	$11.08 - $19.08 $1.15 Million - $1.98 Million	103,633 Added 77.99%	236,516 $3.45 Million
Q1 2022 May 16, 2022	BUY	$14.49 - $24.28 $45,513 - $76,263	3,141 Added 2.42%	132,883 $2.24 Million
Q4 2021 Feb 14, 2022	BUY	$21.21 - $29.68 $62,357 - $87,259	2,940 Added 2.32%	129,742 $2.92 Million
Q3 2021 Nov 15, 2021	BUY	$21.45 - $29.22 $164,328 - $223,854	7,661 Added 6.43%	126,802 $2.73 Million
Q2 2021 Aug 16, 2021	BUY	$27.16 - $38.59 $509,440 - $723,832	18,757 Added 18.69%	119,141 $3.45 Million
Q1 2021 May 17, 2021	BUY	$27.37 - $47.25 $95,795 - $165,375	3,500 Added 3.61%	100,384 $3.24 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $49.62 $1.86 Million - $4.81 Million	96,884 New	96,884 $4 Million

Others Institutions Holding TARS

# of Institutions

170

Shares Held

43.3M

Call Options Held

484K

Put Options Held

4.1K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.42B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Tarsus Pharmaceuticals, Inc. Transaction History